Neurologic - Immunovant Sciences GmbH
Neurologic
Status:
Open/EnrollingClinicalTrials.gov:
NCT05581199A Phase 2b, Multi-center, Randomized, Quadruple-blind, Placebo-controlled Study of Batoclimab Treatment in Adult Participants With Active Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)